Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of the European Academy of Dermatology and Venereology : JEADV|April 28, 2023
Efficacy of imiquimod in the management of lentigo malignaMarie Daude, Monica Dinulescu, Jean-Michel Nguyen, et al.
Cancer|December 8, 2024
Methods of nivolumab administration in advanced melanoma: A comparison of patients' clinical outcomes treated with flat dose or weight-adjusted dose, a multicenter observational studyIona Campo Le Brun, Séphane Dalle, Laurent Mortier, et al.
Annals of the Rheumatic Diseases|July 5, 2022
Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case-control studyLéo Plaçais, Stéphane Dalle, Olivier Dereure, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2019
Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohortPauline Tétu, Clara Allayous, Bastien Oriano, et al.
JAMA Dermatology|May 2, 2019
Association of Time From Primary Diagnosis to First Distant Relapse of Metastatic Melanoma With Progression of Disease and SurvivalAnaïs Vallet, Bastien Oriano, Laurent Mortier, et al.
Eclinicalmedicine|December 24, 2024
When to stop immunotherapy for advanced melanoma: the emulated target trialsMathilde Amiot, Laurent Mortier, Stéphane Dalle, et al.
JAMA Dermatology|July 16, 2020
Association of Anti-Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic MelanomaAngélique Brunot, Jean-Jacques Grob, Geraldine Jeudy, et al.
The British Journal of Dermatology|November 28, 2024
The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world settingKarine Billard, Laurent Mortier, Olivier Dereure, et al.
The Journal of Investigative Dermatology|August 28, 2017
STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer NetworkJulie Delyon, Sylvie Chevret, Thomas Jouary, et al.
European Journal of Cancer (Oxford, England : 1990)|July 25, 2025
Brain metastases from Merkel cell carcinoma: A nationwide retrospective studyRaphaëlle Caillot, Astrid Blom, Céleste Lebbé, et al.
Pageof 4